Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
$26.10
-1.9%
$22.77
$17.86
$29.62
$1.28B2792,914 shs695,468 shs
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
$2.95
-0.7%
$3.93
$1.96
$6.16
$336.44M1.711.25 million shs1.03 million shs
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$30.54
-1.4%
$30.61
$25.73
$48.76
$1.30B1.32267,641 shs303,169 shs
iRadimed Corporation stock logo
IRMD
iRadimed
$93.60
-2.8%
$90.89
$55.11
$107.90
$1.20B0.91148,581 shs175,213 shs
Beginner's Guide To Retirement Stocks Cover

Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
0.00%-2.06%+23.93%+42.16%+9.94%
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
0.00%-2.64%-23.58%-41.00%-10.06%
Cadre Holdings, Inc. stock logo
CDRE
Cadre
0.00%+2.14%+0.01%-3.58%-15.50%
iRadimed Corporation stock logo
IRMD
iRadimed
0.00%+0.57%+7.72%-6.11%+55.97%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
$26.10
-1.9%
$22.77
$17.86
$29.62
$1.28B2792,914 shs695,468 shs
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
$2.95
-0.7%
$3.93
$1.96
$6.16
$336.44M1.711.25 million shs1.03 million shs
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$30.54
-1.4%
$30.61
$25.73
$48.76
$1.30B1.32267,641 shs303,169 shs
iRadimed Corporation stock logo
IRMD
iRadimed
$93.60
-2.8%
$90.89
$55.11
$107.90
$1.20B0.91148,581 shs175,213 shs
Beginner's Guide To Retirement Stocks Cover

Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
0.00%-2.06%+23.93%+42.16%+9.94%
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
0.00%-2.64%-23.58%-41.00%-10.06%
Cadre Holdings, Inc. stock logo
CDRE
Cadre
0.00%+2.14%+0.01%-3.58%-15.50%
iRadimed Corporation stock logo
IRMD
iRadimed
0.00%+0.57%+7.72%-6.11%+55.97%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
2.40
Hold$32.0022.61% Upside
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
3.11
Buy$12.63327.97% Upside
Cadre Holdings, Inc. stock logo
CDRE
Cadre
2.57
Moderate Buy$39.7530.16% Upside
iRadimed Corporation stock logo
IRMD
iRadimed
3.00
Buy$120.0028.21% Upside

Current Analyst Ratings Breakdown

Latest CATX, CDRE, BLFS, and IRMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/4/2026
Cadre Holdings, Inc. stock logo
CDRE
Cadre
UpgradeStrong SellHold
5/20/2026
Cadre Holdings, Inc. stock logo
CDRE
Cadre
DowngradeHold (C+)Hold (C)
5/20/2026
iRadimed Corporation stock logo
IRMD
iRadimed
DowngradeBuy (B)Buy (B-)
5/13/2026
Cadre Holdings, Inc. stock logo
CDRE
Cadre
Reiterated RatingBuy$40.00
5/13/2026
Cadre Holdings, Inc. stock logo
CDRE
Cadre
Set Price Target$40.00
5/12/2026
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
DowngradeStrong-BuyHold
5/6/2026
Cadre Holdings, Inc. stock logo
CDRE
Cadre
DowngradeBuy (B-)Hold (C+)
5/6/2026
iRadimed Corporation stock logo
IRMD
iRadimed
UpgradeBuy (B-)Buy (B)
5/6/2026
Cadre Holdings, Inc. stock logo
CDRE
Cadre
DowngradeHoldStrong Sell
5/5/2026
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
Reiterated RatingOutperform$11.00
4/20/2026
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
Reiterated RatingSell (D-)
(Data available from 6/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
$96.21M13.25$0.23 per share113.98$7.72 per share3.38
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
$880K382.33N/AN/A$2.79 per share1.06
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$610.31M2.14$1.61 per share18.94$7.82 per share3.91
iRadimed Corporation stock logo
IRMD
iRadimed
$83.81M14.27$1.86 per share50.35$7.44 per share12.58
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
-$4.59M-$0.08N/A130.50N/A-2.80%1.81%1.65%8/6/2026 (Estimated)
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
-$103.12MN/AN/AN/AN/A-17,982.69%-42.33%-35.05%8/12/2026 (Estimated)
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$44.14M$0.8934.3121.51N/A5.80%12.39%5.08%8/4/2026 (Estimated)
iRadimed Corporation stock logo
IRMD
iRadimed
$22.48M$1.8351.15N/AN/A27.36%24.48%21.25%7/30/2026 (Estimated)

Latest CATX, CDRE, BLFS, and IRMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/11/2026Q1 2026
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
-$0.29-$0.25+$0.04-$0.25$0.16 million$0.08 million
5/7/2026Q1 2026
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
$0.01$0.04+$0.03$0.02$25.66 million$27.50 million
5/1/2026Q1 2026
iRadimed Corporation stock logo
IRMD
iRadimed
$0.46$0.49+$0.03$0.45$21.32 million$21.98 million
3/16/2026Q4 2025
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
N/A-$0.51N/A-$0.51N/A$0.04 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
N/AN/AN/AN/AN/A
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
N/AN/AN/AN/AN/A
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$0.401.31%N/A44.94%2 Years
iRadimed Corporation stock logo
IRMD
iRadimed
$0.800.85%N/A43.72%1 Years

Latest CATX, CDRE, BLFS, and IRMD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/30/2026
iRadimed Corporation stock logo
IRMD
iRadimed
quarterly$0.200.93%5/15/20265/15/20265/29/2026
4/21/2026
Cadre Holdings, Inc. stock logo
CDRE
Cadre
quarterly$0.101.34%5/1/20265/1/20265/15/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
N/A
7.30
5.50
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
N/A
8.75
8.75
Cadre Holdings, Inc. stock logo
CDRE
Cadre
1.04
2.26
1.33
iRadimed Corporation stock logo
IRMD
iRadimed
N/A
7.13
6.15

Institutional Ownership

CompanyInstitutional Ownership
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
93.24%
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
54.66%
Cadre Holdings, Inc. stock logo
CDRE
Cadre
43.95%
iRadimed Corporation stock logo
IRMD
iRadimed
92.34%

Insider Ownership

CompanyInsider Ownership
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
2.20%
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
2.99%
Cadre Holdings, Inc. stock logo
CDRE
Cadre
30.10%
iRadimed Corporation stock logo
IRMD
iRadimed
34.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
44048.86 million47.78 millionOptionable
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
70114.05 million110.64 millionOptionable
Cadre Holdings, Inc. stock logo
CDRE
Cadre
2,53342.80 million29.92 millionOptionable
iRadimed Corporation stock logo
IRMD
iRadimed
11012.78 million8.36 millionOptionable

Recent News About These Companies

iRadimed (NASDAQ:IRMD) CEO Sells $226,500.00 in Stock
IRadimed Rides 3870 Momentum Despite Near-Term Dip
Iradimed Corp Eyes 2026 Surge After Strong Quarter
iRadimed (NASDAQ:IRMD) CEO Sells $261,144.06 in Stock

New MarketBeat Followers Over Time

Media Sentiment Over Time

BioLife Solutions stock logo

BioLife Solutions NASDAQ:BLFS

$26.10 -0.50 (-1.88%)
Closing price 06/12/2026 04:00 PM Eastern
Extended Trading
$25.90 -0.20 (-0.77%)
As of 06/12/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

Perspective Therapeutics stock logo

Perspective Therapeutics NYSEAMERICAN:CATX

$2.95 -0.02 (-0.67%)
Closing price 06/12/2026 04:10 PM Eastern
Extended Trading
$3.02 +0.07 (+2.34%)
As of 06/12/2026 06:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Perspective Therapeutics, Inc., together with its subsidiaries, develops precision-targeted alpha therapies (TAT) for oncology that treats cancer patients across multiple tumor types comprising metastatic disease. The company discovers, designs, and develop its initial programs candidates consists of VMT-a-NET, that is currently in Phase 1/2a clinical trials for patients with unresectable or metastatic somatostatin receptor type 2 (SSTR2) expressing tumors that have not previously received peptide-targeted radiopharmaceutical therapy, such as Lutathera, a beta-emitting therapy; and VMT01, which is currently in Phase 1/2a clinical trials for second-line or later treatment of patients with progressive melanocortin 1 receptor (MC1R) positive metastatic melanoma. Perspective Therapeutics, Inc. has a clinical trial collaboration agreement with Bristol Myers Squibb to evaluate the safety and tolerability of [212Pb] VMT01 in combination with nivolumab in patients with histologically confirmed melanoma and positive MC1R imaging scans. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is headquartered in Seattle, Washington.

Cadre stock logo

Cadre NYSE:CDRE

$30.54 -0.42 (-1.36%)
Closing price 06/12/2026 03:59 PM Eastern
Extended Trading
$30.45 -0.09 (-0.29%)
As of 06/12/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cadre Holdings, Inc. manufactures and distributes safety that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It offers body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brand names; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products. The company also offers third-party products, such as uniforms, optics, boots, firearms, and ammunition. It serves first responders, such as state and local law enforcement, fire and rescue, explosive ordnance disposal technicians, emergency medical technicians, fishing, and wildlife enforcement and departments of corrections, as well as federal agencies including the U.S. Department of State, U.S. Department of Defense, U.S. Department of Interior, U.S. Department of Justice, U.S. Department of Homeland Security, U.S. Department of Corrections, the Department of Energy, Los Alamos National Laboratories, Waste Isolation Plant, and various foreign government agencies. Cadre Holdings, Inc. was founded in 1964 and is headquartered in Jacksonville, Florida.

iRadimed stock logo

iRadimed NASDAQ:IRMD

$93.60 -2.66 (-2.76%)
Closing price 06/12/2026 04:00 PM Eastern
Extended Trading
$93.56 -0.04 (-0.05%)
As of 06/12/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.